Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAGED-PKD phase 3 trial of venglustat in rapidly progressive ADPKD
MOH_2021-01-04_009228Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autosomal dominant polycystic kidney disease (ADPKD) comparing Venglustat with Placebo (2 arms). Primary endpoint: Rate of decline in kidney function. Started Dec 2020; status: completed.
02
Drugs
venglustat
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on MOH_2021-01-04_009228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-01-04_009228.